by Stephane Cailmail | 6 Dec 2019 | General news, Research
A multi-year framework agreement has just been signed by 3 major stakeholders present on the Oncopole campus in Toulouse: the Pierre Fabre Research Institute (IRPF), the Centre de Recherches en Cancérologie de Toulouse (CRCT-Inserm) and the Institut Universitaire du...
by Sébastien Guibert | 27 Nov 2019 | General news, Research
Prof. Hervé Avet-Loiseau, head of the “Myeloma Genomics” unit at IUCT-Oncopole and the “Oncogenomics and immunology of myeloma” team at CRCT is on Clarivate Analytics’ list of the most influential researchers of the past decade. This is a...
by Sébastien Guibert | 15 Jan 2019 | General news, Research
IMLINFO is a cross-border network of personalized immunotherapies for Non-Hodgkin’s lymphomas (NHL) involving 7 organizations located in Spain and France. Its main objective is to determine the efficacy of new immunotherapy treatments through the creation of a...
by Sébastien Guibert | 3 Apr 2018 | General news, Research
Discover in this France 3 TV report the collaboration between the CRCT team led by Dr. Pierre Cordelier and the Toulouse start-up Neovirtech: a therapeutic innovation opening up new perspectives in the treatment of cancer....
by Sébastien Guibert | 22 Mar 2018 | General news, Research
Thanks to anticancer immunotherapies targeting immune checkpoints, the proportion of patients with metastatic melanoma (MM) in remission after 5 years has tripled during the last years. However, therapeutic options are sparse for patients who do not respond to...
by Sébastien Guibert | 29 Nov 2017 | General news
Pr. Hervé Avet-Loiseau, Director of CRCT’s team 13 “Pharmacogenomics of multiple myeloma” and Director of IUCT-O’s Unit “Genomics of Myeloma” is laureate of the 2017 Prize Rosen from the Fondation pour la Recherche Médicale (FRM)...
